Skip to main content

Articles

244 result(s) within Volume 14 of Radiation Oncology

Page 2 of 5

  1. Stereotactic body radiation therapy (SBRT) was found effective in treating laryngeal cancer with only five treatment fractions by a recent clinical trial (NCT01984502, ClinicalTrials.gov). Nevertheless, this t...

    Authors: You Zhang, Tsuicheng Chiu, Jeffrey Dubas, Zhen Tian, Pam Lee, Xuejun Gu, Yulong Yan, David Sher, Robert Timmerman and Bo Zhao
    Citation: Radiation Oncology 2019 14:193
  2. To determine the biological correlation between apparent diffusion coefficient (ADC) values and Sirtuin1 (SIRT1) levels of tumour tissues in patients with esophageal carcinoma (EC), and to ascertain the treatm...

    Authors: Ying Chen, Tieming Xie, Zhimin Ye, Fangzheng Wang, Dan Long, Mingxiang Jiang, Jun Fang, Qingren Lin, Kai Li, Zhun Wang and Zhenfu Fu
    Citation: Radiation Oncology 2019 14:192
  3. Re-irradiation (re-RT) has the active effect of relieving clinical symptoms and prolonging the survival of patients with recurrent esophageal squamous cell carcinoma (ESCC). However, the optimal re-RT dose is ...

    Authors: Xiujuan Xu, Zhongming Wang, Shunian Jiang, Yuping Shang and Yan Wu
    Citation: Radiation Oncology 2019 14:191
  4. We aimed to ascertain population-based practice patterns and survival outcomes of postoperative radiotherapy following breast conserving-surgery (BCS) in elderly women (aged ≥65 years) with early-stage pure mu...

    Authors: San-Gang Wu, Feng-Yan Li, Jun Wang, Chen-Lu Lian, Juan Zhou and Zhen-Yu He
    Citation: Radiation Oncology 2019 14:190
  5. Patients treated with radiotherapy for head and neck (H&N) cancer often experience anatomical changes. The potential compromises to Planning Target Volume (PTV) coverage or Organ at Risk (OAR) sparing has prom...

    Authors: Louise Belshaw, Christina E. Agnew, Denise M. Irvine, Keith P. Rooney and Conor K. McGarry
    Citation: Radiation Oncology 2019 14:189
  6. Thoracic and head and neck cancer radiation therapy (RT) can cause damage to nearby healthy organs such as the esophagus, causing acute radiation-induced esophageal damage (ARIED). A non-invasive method to det...

    Authors: Pouya Jelvehgaran, Jeffrey D. Steinberg, Artem Khmelinskii, Gerben Borst, Ji-Ying Song, Niels de Wit, Daniel M. de Bruin and Marcel van Herk
    Citation: Radiation Oncology 2019 14:188
  7. To determine if the performance of a knowledge based RapidPlan (RP) planning model could be improved with an iterative learning process, i.e. if plans generated by an RP model could be used as new input to re-...

    Authors: A. Fogliata, L. Cozzi, G. Reggiori, A. Stravato, F. Lobefalo, C. Franzese, D. Franceschini, S. Tomatis and M. Scorsetti
    Citation: Radiation Oncology 2019 14:187
  8. Tumor motion may compromise the accuracy of liver stereotactic radiotherapy. In order to carry out a precise planning, estimating liver tumor motion during radiotherapy has received a lot of attention. Previou...

    Authors: Wu-zhou Li, Zhi-wen Liang, Yi Cao, Ting-ting Cao, Hong Quan, Zhi-yong Yang, Qin Li and Zhi-tao Dai
    Citation: Radiation Oncology 2019 14:185
  9. Stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) are well established local treatment approaches in several cancer settings. Although SBRT is still under investigation for spinal metas...

    Authors: Niccolò Giaj-Levra, Maximilian Niyazi, Vanessa Figlia, Giuseppe Napoli, Rosario Mazzola, Luca Nicosia, Stefanie Corradini, Ruggero Ruggieri, Giuseppe Minniti and Filippo Alongi
    Citation: Radiation Oncology 2019 14:184
  10. To quantify the effects of the Bragg peak degradation due to lung tissue on treatment plans of lung cancer patients with spot scanning proton therapy and to give a conservative approximation of these effects.

    Authors: Kilian-Simon Baumann, Veronika Flatten, Uli Weber, Stefan Lautenschläger, Fabian Eberle, Klemens Zink and Rita Engenhart-Cabillic
    Citation: Radiation Oncology 2019 14:183

    The Correction to this article has been published in Radiation Oncology 2020 15:29

  11. Patients with N3 stage nasopharyngeal carcinoma (NPC) are at high risk for treatment failure. This study aims to assess the efficacy of maintenance chemotherapy (MC) using S-1 (MC-S1), a novel oral fluoropyrim...

    Authors: Jingfeng Zong, Hanchuan Xu, Bijuan Chen, Qiaojuan Guo, Yun Xu, Chuanben Chen, Youliang Weng, Wei Zheng, Jianji Pan and Shaojun Lin
    Citation: Radiation Oncology 2019 14:182
  12. We aimed to identify the risk factors and provide a nomogram for the prediction of radiotherapy-related esophageal fistula in patients with esophageal cancer (EC) using a case-control study.

    Authors: Yiyue Xu, Linlin Wang, Bo He, Wanlong Li, Qiang Wen, Shijiang Wang, Xindong Sun, Xue Meng and Jinming Yu
    Citation: Radiation Oncology 2019 14:181
  13. This study aimed to compare the clinical outcomes of stereotactic ablative radiotherapy (SABR) and conventionally fractionated radiotherapy (CFRT) in hepatocellular carcinoma (HCC) patients with portal vein in...

    Authors: Jen-Fu Yang, Cheng-Hsiang Lo, Meei-Shyuan Lee, Chun-Shu Lin, Yang-Hong Dai, Po-Chien Shen, Hsing-Lung Chao and Wen-Yen Huang
    Citation: Radiation Oncology 2019 14:180
  14. To assess late toxicity, quality of life and oncological outcome after consolidative whole abdominal radiotherapy (WART) following cytoreductive surgery and carboplatin/paclitaxel chemotherapy in high risk pat...

    Authors: Nathalie Arians, Meinhard Kieser, Laura Benner, Nathalie Rochet, Lars Schröder, Sonja Katayama, Klaus Herfarth, Kai Schubert, Andreas Schneeweiss, Christof Sohn, Katja Lindel and Jürgen Debus
    Citation: Radiation Oncology 2019 14:179
  15. Radiation Therapy Oncology Group (RTOG) 94–05 has demonstrated that higher dose radiation didn’t improve outcome of patients with esophageal cancer (EC). However, several retrospective studies showed that a hi...

    Authors: He-San Luo, He-Cheng Huang and Lian-Xing Lin
    Citation: Radiation Oncology 2019 14:178
  16. There is no general consensus on the optimal treatment for prostate cancer (PC) patients with intrapelvic nodal oligorecurrences after radical prostatectomy. Besides androgen deprivation therapy (ADT) as stand...

    Authors: Cedric Panje, Thomas Zilli, Alan Dal Pra, Winfried Arnold, Kathrin Brouwer, Helena I. Garcia Schüler, Silvia Gomez, Fernanda Herrera, Kaouthar Khanfir, Alexandros Papachristofilou, Gianfranco Pesce, Christiane Reuter, Hansjörg Vees, Daniel Zwahlen and Paul Martin Putora
    Citation: Radiation Oncology 2019 14:177
  17. To assess the comparative efficacy and safety of elective nodal irradiation (ENI) and involved-field irradiation (IFI) in patients with esophageal cancer (EC) receiving neoadjuvant chemoradiotherapy plus surge...

    Authors: Tingting Liu, Silu Ding, Jun Dang, Hui Wang, Jun Chen and Guang Li
    Citation: Radiation Oncology 2019 14:176
  18. We evaluated the long-term outcomes and late toxicity of conventional fractionated (CF) and hypofractionated (HF) postmastectomy radiotherapy (PMRT) in terms of locoregional recurrence-free survival (LRRFS), d...

    Authors: Imjai Chitapanarux, Pitchayaponne Klunklin, Attapol Pinitpatcharalert, Patumrat Sripan, Ekkasit Tharavichitkul, Wannapha Nobnop, Wimrak Onchan, Somvilai Chakrabandhu, Bongkot Jia-Mahasap, Juntima Euathrongchit, Yutthaphan Wannasopha and Tanop Srisuwan
    Citation: Radiation Oncology 2019 14:175
  19. This study aimed to evaluate the clinical and dosimetric factors predictive of acute anal toxicity (AAT) after radiotherapy in prostate cancer (PCa) patients with or without hemorrhoids.

    Authors: Xingsi Peng, Sha Zhou, Shiliang Liu, Jibin Li, Sijuan Huang, Xiaobo Jiang, Maosheng Lin, Shaomin Huang, Chengguang Lin, Chaonan Qian, Mengzhong Liu and Liru He
    Citation: Radiation Oncology 2019 14:174
  20. Ultrasound (US) imaging has been proved as an excellent diagnostic tool in gynecology and, due to its wide availability and limited cost, is under intense investigation as base for dose adaptation in cervical ...

    Authors: Mario Federico, Carmen Rosa Hernandez-Socorro, Ivone Ribeiro, Jesus Gonzalez Martin, Maria Dolores Rey-Baltar Oramas, Marta Lloret Saez-Bravo and Pedro Carlos Lara Jimenez
    Citation: Radiation Oncology 2019 14:173
  21. Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial MC ...

    Authors: P.-H. Mackeprang, D. Vuong, W. Volken, D. Henzen, D. Schmidhalter, M. Malthaner, S. Mueller, D. Frei, W. Kilby, D. M. Aebersold, M. K. Fix and P. Manser
    Citation: Radiation Oncology 2019 14:172
  22. Prophylactic cranial irradiation (PCI) is indicated for limited-stage small cell lung cancer (LS-SCLC) with good response to chemoradiotherapy (CRT). However, brain metastasis (BM) developed in LS-SCLC before ...

    Authors: Xiao Chu, Shuyan Li, Bingqing Xia, Li Chu, Xi Yang, Jianjiao Ni, Liqing Zou, Yida Li, Congying Xie, Jie Lin and Zhengfei Zhu
    Citation: Radiation Oncology 2019 14:171
  23. Pathogenesis of brain metastases/meningeal cancer and the emotional and neurological outcomes are not yet well understood. The hypothesis of our study is that patients with leptomeningeal cancer show volumetri...

    Authors: Michael Mayinger, Antonia Reibelt, Kai Joachim Borm, Johannes Ettl, Jan J. Wilkens, Stephanie Elisabeth Combs, Markus Oechsner and Marciana Nona Duma
    Citation: Radiation Oncology 2019 14:170
  24. Leptomeningeal metastasis (LM) is a devastating and terminal complication of advanced non-small-cell lung cancer (NSCLC), especially in patients harboring epidermal growth factor receptor (EGFR) mutations. The...

    Authors: Weiwei Yan, Yang Liu, Ji Li, Anqin Han, Li Kong, Jinming Yu and Hui Zhu
    Citation: Radiation Oncology 2019 14:168
  25. The purpose of this study was to assess the feasibility, efficacy and toxicity of fiducial marker implantation and tracking in CyberKnife® stereotactic radiation therapy (SBRT) applied to extracranial locations.

    Authors: Nathaniel Scher, Marc Bollet, Gauthier Bouilhol, Remi Tannouri, Imane Khemiri, Aurelie Vouillaume, Noura Sellami, Rie Von Eyben, Jean-Michel Vannetzel, Ilan Darmon, Luc Rotenberg, Hanah Lamallem, Olivier Bauduceau, Denis Foster and Alain Toledano
    Citation: Radiation Oncology 2019 14:167
  26. Sarcopenia, the critical depletion of skeletal muscle mass, is an independent prognostic factor in several tumor entities for treatment-related toxicity and survival. In esophageal cancer, there have been conf...

    Authors: Cédric M. Panje, Laura Höng, Stefanie Hayoz, Vickie E. Baracos, Evelyn Herrmann, Helena Garcia Schüler, Urs R. Meier, Guido Henke, Sabina Schacher, Hanne Hawle, Marie-Aline Gérard, Thomas Ruhstaller and Ludwig Plasswilm
    Citation: Radiation Oncology 2019 14:166
  27. To provide fast and accurate dose calculation in voxelized geometries for proton radiation therapy by implementing an adaptive step size algorithm in the proton macro Monte Carlo (pMMC) method.

    Authors: Reto Kueng, Daniel Frei, Werner Volken, Fabian Stuermlin, Marco F. M. Stampanoni, Daniel M. Aebersold, Peter Manser and Michael K. Fix
    Citation: Radiation Oncology 2019 14:165
  28. In prostate cancer patients, imaging of bone metastases is enhanced through the use of sodium fluoride positron emission tomography (18F-NaF PET/CT). This imaging technique shows areas of enhanced osteoblastic ac...

    Authors: Nicholas Hardcastle, Michael S. Hofman, Ching-Yu Lee, Jason Callahan, Lisa Selbie, Farshad Foroudi, Mark Shaw, Sarat Chander, Andrew Lim, Brent Chesson, Declan G. Murphy, Tomas Kron and Shankar Siva
    Citation: Radiation Oncology 2019 14:164
  29. To determine the feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation (Hypo-IGRT) in locally advanced node-positive non-small cell lung cancer patients with highly compromise...

    Authors: Chukwuka Eze, Julian Taugner, Olarn Roengvoraphoj, Nina-Sophie Schmidt-Hegemann, Lukas Käsmann, Cherylina Wijaya, Claus Belka and Farkhad Manapov
    Citation: Radiation Oncology 2019 14:163
  30. The treatment of lung lesions with stereotactic body radiation therapy calls for highly conformal dose, which is evaluated by a number of metrics. Lung stereotactic body radiation therapy clinical trials const...

    Authors: David Hoffman, Irena Dragojević, Jeremy Hoisak, David Hoopes and Ryan Manger
    Citation: Radiation Oncology 2019 14:162
  31. The prognosis of N categories for patients with non-surgical esophageal carcinoma based on the number of metastatic lymph nodes is controversial. The present study analyzes prognostic implications of the numbe...

    Authors: Zongxing Zhao, Yanan Zhang, Peiliang Wang, Xin Wang and Minghuan Li
    Citation: Radiation Oncology 2019 14:161
  32. Meningiomas are the most common primary tumors of the central nervous system. In patients with WHO grade I meningiomas no adjuvant therapy is recommended after resection. In case of anaplastic meningiomas (WHO...

    Authors: Saman Moritz Hemmati, Pirus Ghadjar, Arne Grün, Harun Badakhshi, Sebastian Zschaeck, Carolin Senger, Güliz Acker, Martin Misch, Volker Budach and David Kaul
    Citation: Radiation Oncology 2019 14:160
  33. This study aimed to evaluate the impact of previous local treatment on lymphatic drainage patterns in ipsilateral breast tumor recurrence (IBTR) based on our data on re-operative sentinel lymph node biopsy (re...

    Authors: Ayaka Sato, Takehiko Sakai, Takuji Iwase, Fumiko Kano, Kiyomi Kimura, Akiko Ogiya, Mitsuru Koizumi, Masahiko Tanabe, Rie Horii, Futoshi Akiyama, Takayuki Ueno and Shinji Ohno
    Citation: Radiation Oncology 2019 14:159
  34. To report results from our phase I dose-escalation study of stereotactic body radiotherapy (SBRT) using 4 fractions for patients with localized prostate cancer.

    Authors: Takuro Kainuma, Shogo Kawakami, Hideyasu Tsumura, Takefumi Satoh, Ken-ichi Tabata, Masatsugu Iwamura, Kazushige Hayakawa and Hiromichi Ishiyama
    Citation: Radiation Oncology 2019 14:158
  35. Radiotherapy is frequently used in the therapy of lymphoma. Since lymphoma, for example Hodgkin’s disease, frequently affect rather young patients, the induction of secondary cancer or other long-term adverse ...

    Authors: S. Lautenschlaeger, G. Iancu, V. Flatten, K. Baumann, M. Thiemer, C. Dumke, K. Zink, H. Hauswald, D. Vordermark, C. Mauz-Körholz, R. Engenhart-Cabillic and F. Eberle
    Citation: Radiation Oncology 2019 14:157
  36. Adjuvant radiotherapy is the standard treatment after breast-conserving surgery. According to meta-analyses, adjuvant 3d-conventional irradiation reduces the risk of local recurrence and thereby improves long-...

    Authors: Daniel Karpf, Mazen Sakka, Martin Metzger and Gerhard G. Grabenbauer
    Citation: Radiation Oncology 2019 14:156
  37. Transforming growth factor beta 1 (TGF-β1) and platelet-derived growth factor (PDGF) are cytokines involved in fibrotic processes causing radiotherapy (RT)-induced cardiovascular changes. We aimed to investiga...

    Authors: Hanna Aula, Tanja Skyttä, Suvi Tuohinen, Tiina Luukkaala, Mari Hämäläinen, Vesa Virtanen, Pekka Raatikainen, Eeva Moilanen and Pirkko-Liisa Kellokumpu-Lehtinen
    Citation: Radiation Oncology 2019 14:155
  38. Target localization in radiation therapy is affected by numerous sources of uncertainty. Despite measures to minimize the breathing motion, the treatment of hypofractionated liver radiation therapy is further ...

    Authors: Gye Won Choi, Yelin Suh, Prajnan Das, Joseph Herman, Emma Holliday, Eugene Koay, Albert C. Koong, Sunil Krishnan, Bruce D. Minsky, Grace L. Smith, Cullen M. Taniguchi and Sam Beddar
    Citation: Radiation Oncology 2019 14:154
  39. The heart and lungs are routinely exposed to incidental irradiation during adjuvant radiotherapy (RT) of breast cancer. We analyzed the impact of patient and treatment characteristics on heart and lung dose in...

    Authors: Tobias Finazzi, Van-Trinh Nguyen, Frank Zimmermann and Alexandros Papachristofilou
    Citation: Radiation Oncology 2019 14:153
  40. Nutritional status and haematological parameters are related to the prognosis of patients treated with radiotherapy, but the correlation between adaptive radiotherapy (ART) and haematological indicators has ne...

    Authors: Ning Han, Xintong Lyu, Guang Li and Qiao Qiao
    Citation: Radiation Oncology 2019 14:151
  41. Measurement of γ-H2AX foci levels in cells provides a sensitive and reliable method for quantitation of the radiation-induced DNA damage response. The objective of the present study was to develop a rapid, hig...

    Authors: Younghyun Lee, Qi Wang, Igor Shuryak, David J. Brenner and Helen C. Turner
    Citation: Radiation Oncology 2019 14:150
  42. The present prospective study evaluated the safety and efficacy of the rectum following KUSHEN Ningjiaos in cervical cancer. We compared rectal wall changes during brachytherapy with or without KUSHEN Ningjiaos i...

    Authors: Xiaojuan Li, Cheng Xiao, Yilin Kong, Weiwei Guo, Wenting Zhan, Gong Li, Xuetao Wang, Bailin Zhang and Lei Gao
    Citation: Radiation Oncology 2019 14:149
  43. To evaluate and establish a digital workflow for the custom designing and 3D printing of mouth opening tongue-depressing (MOTD) stents for patients receiving radiotherapy for head and neck cancer.

    Authors: Mohamed Zaid, Nimit Bajaj, Hannah Burrows, Ryan Mathew, Annie Dai, Christopher T. Wilke, Stephen Palasi, Ryan Hergenrother, Caroline Chung, Clifton D. Fuller, Jack Phan, G. Brandon Gunn, William H. Morrison, Adam S. Garden, Steven J. Frank, David I. Rosenthal…
    Citation: Radiation Oncology 2019 14:148
  44. There is continued debate regarding the optimal combinations of radiation therapy and chemotherapy in the preoperative treatment of locally advanced rectal adenocarcinomas. We report our single-institution exp...

    Authors: Angela Y. Jia, Amol Narang, Bashar Safar, Atif Zaheer, Adrian Murphy, Nilofer S. Azad, Susan Gearhart, Sandy Fang, Jonathan Efron, Tam Warczynski, Amy Hacker-Prietz and Jeffrey Meyer
    Citation: Radiation Oncology 2019 14:147
  45. At present, the standard treatment approach for locally advanced cervical cancer is concurrent chemoradiotherapy (CCRT). An elevated pretreatment squamous cell carcinoma antigen (SCC Ag) level is associated wi...

    Authors: Jingxuan Fu, Weiping Wang, Yidan Wang, Chengeng Liu and Peichang Wang
    Citation: Radiation Oncology 2019 14:146
  46. Heterogeneous target doses are a common by-product from attempts to improve normal tissue sparing in radiosurgery treatment planning. These regions of escalated dose within the target may increase tumor contro...

    Authors: William T. Hrinivich, Todd R. McNutt and Jeffrey J. Meyer
    Citation: Radiation Oncology 2019 14:145

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions